Concord Biotech IPO final day | Investors buy 6.83 times, retail portion booked 3 times

Concord Biotech IPO | The main objective of the issue is to give a exit to Helix Investment Holdings which has 20 percent stake in the company.

Top 100 Best Sellers

Read More

​ Concord Biotech IPO | The main objective of the issue is to give a exit to Helix Investment Holdings which has 20 percent stake in the company. Concord Biotech IPO | The main objective of the issue is to give a exit to Helix Investment Holdings which has 20 percent stake in the company.  Moneycontrol Latest News Read More